Bristol-Myers Squibb, Teva Settle Litigation Over Paraplatin
Drug maker Bristol-Myers Squibb and Israeli generic drug maker Teva Pharmaceutic Industries have settled patent litigation related to carboplatin injection, the generic version of cancer treatment Paraplatin....To view the full article, register now.
Already a subscriber? Click here to view full article